Loading
glp-2-trz.png
Metabolic Research
GLP-2 TRZ
Tirzepatide (LY3298176)
Latest Result
99.88%
Purity Score
GLP-2 TRZ 20mg
Aug 31, 2026
Measured Content
21.08mgIdentity (MS)
ConfirmedHeavy Metals
Not DetectedSterility
No GrowthEndotoxin
0.071 EU/mLVerify independently
XZN2AEYA
ISO 17025 Accredited · Third-Party USA Lab
GLP-2 TRZ
Dual-receptor agonist. GIP & GLP-1.
Size
In stock
Bundle & Save
$129.99
/ 20mg
1
For Research Use Only - Not for Human Consumption.
Purity
99.88%
Aug 31, 2026
See the COA before you buy.
Sold lyophilized. Ships as a stable freeze-dried powder for laboratory research use.
>=99% Purity
HPLC & MS Tested
See COA First
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Extensively s...
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Extensively studied across the SURPASS and SURMOUNT trial programs, it represents the most rigorously characterized dual incretin peptide in the published metabolic research literature.
Mechanism of Action
Tirzepatide's single-molecule dual agonism at both GIP and GLP-1 receptors has been studied for its receptor binding kinetics and downstream signaling. Research has examined GIP receptor interactions with adipose tissue metabolism pathways, GLP-1 receptor binding and gastric motility signaling, and the combined receptor engagement profile relative to single-agonist approaches.